Pure Global
NCT06086561

Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device

Rhaeos, Inc.·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hydrocephalus
Drug/Device/Intervention
Thermal Anisotropy Measurement Device
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Rhaeos, Inc.
Location
Chicago, United States of America
Timeline & enrollment
Phase
N/A
Start date
Nov 17, 2023
End date
Mar 01, 2024
Enrollment
30 participants
Primary outcome

Skin Temperature,Acceleration

Summary

This study evaluates the performance of a device for non-invasively assessing cerebrospinal
 fluid (CSF) shunt flow. Patients with an existing implanted shunt will wear the device to
 acquire longitudinal data.

ICD-10 classifications
HydrocephalusHydrocephalus, unspecifiedOther hydrocephalusCongenital hydrocephalusObstructive hydrocephalus
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06086561
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06086561 through Pure Global AI's free database. This phase not specified trial is sponsored by Rhaeos, Inc. and is currently Recruiting. The study focuses on Hydrocephalus. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.